WuXi Biologics (Cayman) Inc. carries a market capitalization of 25.77B, placing it among publicly traded companies globally.
| Market Cap | 25.77B |
| Enterprise Value | N/A |
WuXi Biologics (Cayman) Inc.'s stock has gained approximately 34.2246% over the past 52 weeks. The 50-day moving average sits at 10.70, while the 200-day moving average is 9.31.
| Beta (5Y) | N/A |
| 52-Week Price Change | 34.2246% |
| 50-Day Moving Average | 10.70 |
| 200-Day Moving Average | 9.31 |
| Average Volume (20 Days) | N/A |
WuXi Biologics (Cayman) Inc.'s most recent stock split took place on December 10, 2020 with a 1:3 split ratio.
| Last Split Date | 12/10/2020 |
| Split Ratio | 1:3 |